Who are they? And which products will put them up there?
With many of the world's largest pharmaceutical companies continuing to face the loss of patent protection for key drugs, and with the threat of biosimilar competition looming large, news of breakups, spinoffs and acquisitions fill the headlines.
Which companies will ride these turbulent waters and stay on top? What new and existing products will drive their success, and which drugs are going to see the greatest declines?
No single organisation has all the answers. That’s why FirstWord has combined and distilled extensive analysis from experts in many fields to predict the top 10 Pharma companies in 2017.
Each of the top 10 pharma companies for 2017 has its own report, providing an overall sales forecast, individual sales forecasts for the top 5 drivers and resistors, and a detailed account of the key catalysts that will have an impact on those products, such as forthcoming trial results, new competition, and generic incursion
Unlike other pharma reports on the market, FirstWord has drawn on a wide range of respected sources – including investment bank and equity research, analyst briefings, news sources, and company publications – to bring you consensus forecasts, insightful, in-depth analysis, and unbiased predictions for the future leaders of the industry. This report will help you to:
The Top 10 Pharma Companies in 2017 answers key questions including:
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved